Standalone Observational Study Assessing the Performance of an AI/ML Tech-based SaMD on Chest LDCT Images (REALITY)

Clinical trial NCT06576232 · COMPLETED

Trial details

NCT number: NCT06576232
Sponsor: Median Technologies
Status: COMPLETED
Study type: OBSERVATIONAL

High Risk Cancer

Start date: 2022-09-21
Primary completion: 2024-07-24
Enrollment: 1147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.